Deerfield backs a Penn spinout aiming to shake up Parkinson's treatments using stem cells, brain surgery

Max Gelman

Senior Editor

Unlike in other neurodegenerative diseases, such as Alzheimer’s, the pathology of Parkinson’s is relatively well-understood. Researchers have known for decades that the disease affects the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Deerfield backs a Penn spinout aiming to shake up Parkinson's treatments using stem cells, brain surgery

Max Gelman

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Deer­field backs a Penn spin­out aim­ing to shake up Parkin­son's treat­ments us­ing stem cells, brain surgery

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Deerfield backs a Penn spinout aiming to shake up Parkinson's treatments using stem cells, brain surgery